8304 Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 

withdrawn as of February 14, 2022. 

Comments on this notice of intent must 

be submitted on or before April 15, 

2022. 

ADDRESSES: Comments may be 

submitted by any of the following 

methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Email: paperwork.comments@

pbgc.gov. Refer to OMB control number 

1212–0075 in the subject line. 

• Mail or Hand Delivery: Regulatory 

Affairs Division, Office of the General 

Counsel, Pension Benefit Guaranty 

Corporation, 1200 K Street NW, 

Washington, DC 20005–4026. 

Commenters are strongly encouraged 

to submit public comments 

electronically. PBGC expects to have 

limited personnel available to process 

public comments that are submitted on 

paper through mail. Until further notice, 

any comments submitted on paper will 

be considered to the extent practicable. 

All submissions received must 

include the agency’s name (Pension 

Benefit Guaranty Corporation, or PBGC) 

and refer to OMB control number 1212– 

0075. All comments received will be 

posted without change to PBGC’s 

website, http://www.pbgc.gov, including 

any personal information provided. 

Commenters should not include any 

information for which disclosure is 

restricted by statute, such as trade 

secrets and commercial or financial 

information (‘‘confidential business 

information’’). Submission of 

confidential business information 

without a request for protected 

treatment constitutes a waiver of any 

claims of confidentiality. 

Copies of the collection of 

information may be obtained by writing 

to Disclosure Division, Office of the 

General Counsel, Pension Benefit 

Guaranty Corporation, 1200 K Street 

NW, Washington, DC 20005–4026, or 

calling 202–229–4040 during normal 

business hours. If you are deaf, hard of 

hearing, or have a speech disability, 

please dial 7–1–1 to access 

telecommunications relay services. 

FOR FURTHER INFORMATION CONTACT: 

Melissa Rifkin (rifkin.melissa@

pbgc.gov), Attorney, Regulatory Affairs 

Division, Office of the General Counsel, 

Pension Benefit Guaranty Corporation, 

1200 K Street NW, Washington, DC 

20005–4026; 202–229–6563. If you are 

deaf, hard of hearing, or have a speech 

disability, please dial 7–1–1 to access 

telecommunications relay services. 

SUPPLEMENTARY INFORMATION: This 

notice replaces the notice published on 

January 28, 2022 (87 FR 4667), which 

PBGC withdraws. 

Under Executive Order 14043, every 

Federal agency must ‘‘implement, to the 

extent consistent with applicable law, a 

program to require COVID–19 

vaccination for all of its Federal 

employees, with exceptions only as 

required by law.’’ In following this 

directive, the Pension Benefit Guaranty 

Corporation (PBGC) imposed a 

requirement that its employees must 

receive and submit proof of a COVID– 

19 vaccination. As required by 29 U.S.C. 

701 et seq. and 29 CFR part 1630, PBGC 

allows an exception from the 

vaccination requirement for employees 

who demonstrate medical reasons or 

disabilities that would make the 

COVID–19 vaccine unsafe for them. To 

obtain this exception, employees must 

complete the Request for Medical 

Exception to COVID–19 Vaccination 

Requirement form. PBGC uses the 

information on this form to verify 

employees’ assertions that they are 

entitled to an exception to the COVID– 

19 vaccination requirement because of 

their medical or disability statuses. 

The medical exception request 

collection of information has been 

approved by OMB under control 

number 1212–0075 (expires May 31, 

2022). PBGC intends to request that 

OMB extend its approval for 3 years. An 

agency may not conduct or sponsor, and 

a person is not required to respond to, 

a collection of information unless it 

displays a currently valid OMB control 

number. 

PBGC estimates that an average of 2 

employees each year will submit 

Request for Medical Exception to 

COVID–19 Vaccination Requirement 

forms. The total estimated annual 

burden of the collection of information 

is 0.5 hours and $0. 

PBGC is soliciting public comments 

to— 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodologies and assumptions used; 

• Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

A Notice Regarding Injunctions 

The vaccination requirement issued 

pursuant to E.O. 14043 is currently the 

subject of a nationwide injunction. 

While that injunction remains in place, 

PBGC will not process requests for a 

medical exception from the COVID–19 

vaccination requirement pursuant to 

E.O. 14043. PBGC will also not request 

the submission of any medical 

information related to a request for an 

exception from the vaccination 

requirement pursuant to E.O. 14043 

while the injunction remains in place. 

But PBGC may nevertheless receive 

information regarding a medical 

exception. That is because, if PBGC 

were to receive a request for an 

exception from the COVID–19 

vaccination requirement pursuant to 

E.O. 14043 during the pendency of the 

injunction, PBGC will accept the 

request, hold it in abeyance, and notify 

the employee who submitted the request 

that implementation and enforcement of 

the COVID–19 vaccination requirement 

pursuant to E.O. 14043 is currently 

enjoined and that an exception therefore 

is not necessary so long as the 

injunction is in place. In other words, 

during the pendency of the injunction, 

any information collection related to 

requests for medical exception from the 

COVID–19 vaccination requirement 

pursuant to E.O. 14043 is not 

undertaken to implement or enforce the 

COVID–19 vaccination requirement. 

Issued in Washington, DC. 

Hilary Duke, 

Assistant General Counsel for Regulatory 

Affairs, Pension Benefit Guaranty 

Corporation. 

[FR Doc. 2022–03118 Filed 2–11–22; 8:45 am] 

BILLING CODE 7709–02–P 

SECURITIES AND EXCHANGE 

COMMISSION 

Sunshine Act Meetings 

TIME AND DATE: 3:00 p.m. on Thursday, 

February 17, 2022. 

PLACE: The meeting will be held via 

remote means and/or at the 

Commission’s headquarters, 100 F 

Street NE, Washington, DC 20549. 

STATUS: This meeting will be closed to 

the public. 

MATTERS TO BE CONSIDERED: 

Commissioners, Counsel to the 

Commissioners, the Secretary to the 

Commission, and recording secretaries 

will attend the closed meeting. Certain 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 8305 

1 15 U.S.C. 78s(b)(1). 

2 17 CFR 240.19b–4. 

3See Securities Exchange Act Release No. 93849 

(Dec. 22, 2021), 86 FR 74204 (Dec. 29, 2021 

(‘‘Notice’’). 

4 15 U.S.C. 78s(b)(2). 

5The Commission notes that the exchange has a 

different pending proposed rule change that also 

relates to the NYSE Closing Auction. See Securities 

Exchange Act Release No. 93809 (Dec. 17, 2022), 86 

FR 73060 (Dec. 23, 2021) (File No. SR–NYSE–2021– 

44) (Order Instituting Proceedings). 

6 Id. 

7 17 CFR 200.30–3(a)(31). 

1 15 U.S.C. 78s(b)(1). 

2 17 CFR 240.19b–4. 

3See Securities Exchange Act Release No. 92844 

(September 1, 2021), 86 FR 50411 (September 8, 

2021). Comments on the proposed rule change can 

be found at: https://www.sec.gov/comments/srmemx-2021-10/srmemx202110.htm. 

4See Securities Exchange Act Release No. 93383 

(October 19, 2021), 86 FR 58964 (October 25, 2021). 

5See Securities Exchange Act Release No. 93727 

(December 7, 2021), 86 FR 70874 (December 13, 

2021). 

6 In Amendment No. 1, the Exchange, among 

other things: (1) Eliminated the ability for Users 

(defined below) to elect whether to designate an 

RML Order to be identified as such for purposes of 

the Retail Liquidity Identifier, (2) proposes to allow 

Retail Midpoint Orders to trade with both displayed 

odd lot and non-displayed orders priced better than 

the Midpoint Price (defined below) at those orders’ 

ranked prices rather than at the less aggressive 

Midpoint Price, and (3) proposes to allow a Retail 

Midpoint Order to interact with midpoint peg 

orders (i.e., non-RML Orders) that have elected to 

be able to execute in the Retail Midpoint Liquidity 

Program, though only after the Retail Midpoint 

Order has executed against any better priced 

liquidity and any RML Orders. Cf. Investors 

Continued 

staff members who have an interest in 

the matters also may be present. 

In the event that the time, date, or 

location of this meeting changes, an 

announcement of the change, along with 

the new time, date, and/or place of the 

meeting will be posted on the 

Commission’s website at https://

www.sec.gov. 

The General Counsel of the 

Commission, or his designee, has 

certified that, in his opinion, one or 

more of the exemptions set forth in 5 

U.S.C. 552b(c)(3), (5), (6), (7), (8), 9(B) 

and (10) and 17 CFR 200.402(a)(3), 

(a)(5), (a)(6), (a)(7), (a)(8), (a)(9)(ii) and 

(a)(10), permit consideration of the 

scheduled matters at the closed meeting. 

The subject matter of the closed 

meeting will consist of the following 

topics: 

Institution and settlement of 

injunctive actions; 

Institution and settlement of 

administrative proceedings; 

Resolution of litigation claims; and 

Other matters relating to examinations 

and enforcement proceedings. 

At times, changes in Commission 

priorities require alterations in the 

scheduling of meeting agenda items that 

may consist of adjudicatory, 

examination, litigation, or regulatory 

matters. 

CONTACT PERSON FOR MORE INFORMATION: 

For further information; please contact 

Vanessa A. Countryman from the Office 

of the Secretary at (202) 551–5400. 

Authority: 5 U.S.C. 552b. 

Dated: February 10, 2022. 

Vanessa A. Countryman, 

Secretary. 

[FR Doc. 2022–03244 Filed 2–10–22; 4:15 pm] 

BILLING CODE 8011–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Release No. 94181; File No. SR–NYSE– 

2021–74] 

Self-Regulatory Organizations; New 

York Stock Exchange LLC, Notice of 

Designation of a Longer Period for 

Commission Action on a Proposed 

Rule Change To Amend the Provisions 

of Rule 7.35B 

February 8, 2022. 

On December 14, 2021, New York 

Stock Exchange LLC (‘‘NYSE’’) filed 

with the Securities and Exchange 

Commission (‘‘Commission’’), pursuant 

to Section 19(b)(1) of the Securities 

Exchange Act of 1934 (‘‘Act’’) 1 and Rule 

19b–4 thereunder,2 a proposed rule 

change to amend NYSE Rule 7.35B 

relating to the cancellation of MOC, 

LOC, and Closing IO Orders before the 

Closing Auction. The proposed rule 

change was published for comment in 

the Federal Register on December 29, 

2021.3 The Commission has received no 

comments on the proposal. 

Section 19(b)(2) of the Act 4 provides 

that within 45 days of the publication of 

notice of the filing of a proposed rule 

change, or within such longer period up 

to 90 days as the Commission may 

designate if it finds such longer period 

to be appropriate and publishes its 

reasons for so finding or as to which the 

self-regulatory organization consents, 

the Commission shall either approve the 

proposed rule change, disapprove the 

proposed rule change, or institute 

proceedings to determine whether the 

proposed rule change should be 

disapproved. The 45th day after 

publication of the notice for the 

proposed rule change is February 12, 

2022. The Commission is extending this 

45-day time period. 

The Commission finds that it is 

appropriate to designate a longer period 

within which to take action on the 

proposed rule change so that it has 

sufficient time to consider the proposed 

rule change.5 Accordingly, the 

Commission, pursuant to Section 

19(b)(2) of the Act,6 designates March 

29, 2022, as the date by which the 

Commission shall either approve or 

disapprove, or institute proceedings to 

determine whether to approve or 

disapprove, the proposed rule change 

(File No. SR–NYSE–2021–74). 

For the Commission, by the Division of 

Trading and Markets, pursuant to delegated 

authority.7

J. Matthew DeLesDernier, 

Assistant Secretary. 

[FR Doc. 2022–03018 Filed 2–11–22; 8:45 am] 

BILLING CODE 8011–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Release No. 34–94189; File No. SR–MEMX– 

2021–10] 

Self-Regulatory Organizations; MEMX 

LLC; Notice of Filing of Amendment 

No. 1 to, and Designation of a Longer 

Period for Commission Action on 

Proceedings To Determine Whether To 

Approve or Disapprove, a Proposed 

Rule Change To Establish a Retail 

Midpoint Liquidity Program 

February 8, 2022. 

On August 18, 2021, MEMX LLC 

(‘‘MEMX’’ or ‘‘Exchange’’) filed with the 

Securities and Exchange Commission 

(‘‘Commission’’), pursuant to Section 

19(b)(1) of the Securities Exchange Act 

of 1934 (‘‘Act’’) 1 and Rule 19b–4 

thereunder,2 a proposed rule change to 

establish a Retail Midpoint Liquidity 

Program (‘‘Program’’). The proposed 

rule change was published for comment 

in the Federal Register on September 8, 

2021.3 On October 19, 2021, the 

Commission designated a longer period 

within which to approve the proposed 

rule change, disapprove the proposed 

rule change, or institute proceedings to 

determine whether to disapprove the 

proposed rule change.4 On December 7, 

2021, the Commission instituted 

proceedings under Section 19(b)(2)(B) of 

the Act to determine whether to approve 

or disapprove the proposed rule 

change.5 On January 27, 2022, the 

Exchange filed Amendment No. 1 to the 

proposed rule change, which supersedes 

the original filing in its entirety, and is 

described in Items I and II below, which 

Items have been prepared by the 

Exchange.6 The Commission is 


jspears on DSK121TN23PROD with NOTICES1